Beam Therapeutics Inc. Quarterly Marketable Securities, Current in USD from Q4 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Beam Therapeutics Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2022 to Q2 2024.
  • Beam Therapeutics Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $715M, a 15.6% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $715M -$132M -15.6% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $807M -$2.99M -0.37% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $754M -$91.4M -10.8% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 $846M Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $847M Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $810M Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $845M Dec 31, 2022 10-Q 2023-11-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.